Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 3,790 | 10,555 | 5,377 | 4,615 | 9,650 |
Receivables | 2,085 | 3,384 | 2,423 | 8,339 | 4,592 |
Inventories | 4,424 | 3,335 | 3,578 | 3,638 | 3,189 |
TOTAL | $10,854 | $18,114 | $12,635 | $17,658 | $18,531 |
Non-Current Assets | |||||
PPE Net | 1,909 | 1,709 | 2,374 | 2,798 | 1,978 |
Intangibles | 3,264 | 0 | 100 | 257 | 327 |
Other Non-Current Assets | 589 | 752 | 5,707 | 4,297 | 3,651 |
TOTAL | $5,762 | $2,462 | $8,182 | $7,352 | $5,956 |
Total Assets | $16,616 | $20,575 | $20,816 | $25,010 | $24,487 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 3,046 | 3,013 | 2,801 | 4,946 | 4,310 |
TOTAL | $3,096 | $3,406 | $3,155 | $5,286 | $4,310 |
Non-Current Liabilities | |||||
Long Term Debt | 100 | 0 | N/A | N/A | N/A |
Deferred Revenues | 50 | 393 | 353 | 340 | 0 |
TOTAL | $441 | $N/A | $N/A | $N/A | $N/A |
Total Liabilities | $3,537 | $3,406 | $3,155 | $5,286 | $4,310 |
Shareholders' Equity | |||||
Shares Outstanding, K | 14,163 | 12,299 | 9,628 | 9,627 | 9,325 |
Common Shares | 123 | 120 | 96 | 96 | 93 |
Retained earnings | -50,044 | -43,673 | -30,325 | -27,928 | -26,791 |
Other shareholders' equity | 179 | 0 | 0 | 0 | 0 |
TOTAL | $13,079 | $17,170 | $17,662 | $19,724 | $20,177 |
Total Liabilities And Equity | $16,616 | $20,575 | $20,816 | $25,010 | $24,487 |